The availability of suzetrigine may represent a critical step in addressing the nation’s pain management crisis. While ...

I conducted this new systematic review to collate information on the prevalence of animal tranquilizer adulteration of illicit opioid products, the mechanisms of action, and how these new products ...

FDA approval of a novel non-opioid analgesic will hopefully address the needs of many patients with acute pain and improve clinical outcomes and QOL.

Edgecombe, Beaufort and Nash leaders recently described how they're working to cut opioid overdoses, and they all went to the source.

NIH-supported clinical trial shows AI tool as effective as healthcare providers in generating referrals to addiction specialists.

The Down Home representatives specifically asked the commissioners to contribute $500,000 from the opioid settlement. That money would be used to create the agency and create a full-time ...

The National Institute for Standards and Technology’s new harm reduction initiative is helping prevent needless deaths.

"This feedback from the FDA marks a significant milestone for Tharimmune and for individuals who may face the threat of ultrapotent opioid exposure ... levels and duration of action achievable ...

Whether or not threatening tariffs and military action will actually stop ... in 1959 as an alternative to morphine, the dominant painkiller at the time. Fentanyl works faster, is more powerful ...

Trump’s announcement of the largest tariff increases in over a century feels like an economic earthquake. The initial shock ...

Scilex Holding Company (Nasdaq: SCLX, "Scilex" or "Company"), an innovative revenue-generating company focused on acquiring, developing and commercializing ...